Comparing Sintx Technologies (NASDAQ:SINT) & Envoy Medical (NASDAQ:COCH)

Sintx Technologies (NASDAQ:SINT) and Envoy Medical (NASDAQ:COCH) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, institutional ownership and earnings.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Sintx Technologies and Envoy Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1	0	3	0	2.50
Envoy Medical	1	1	1	0	2.00

Sintx Technologies presently has a consensus price target of $9.33, indicating a potential upside of 449.02%. Envoy Medical has a consensus price target of $2.25, indicating a potential upside of 235.52%. Given Sintx Technologies’ stronger consensus rating and higher possible upside, research analysts clearly believe Sintx Technologies is more favorable than Envoy Medical.

Volatility and Risk

Sintx Technologies has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500.

Valuation & Earnings

This table compares Sintx Technologies and Envoy Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02 million	7.20	-$10.36 million	($5.07)	-0.34
Envoy Medical	$240,000.00	214.82	-$23.76 million	($1.01)	-0.66

Sintx Technologies has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 7.1% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Sintx Technologies and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,058.60%	-366.49%	-115.04%
Envoy Medical	-9,875.64%	N/A	-177.92%

Summary

Sintx Technologies beats Envoy Medical on 9 of the 14 factors compared between the two stocks.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.